Top Markets
Coin of the day
ReShape Lifesciences Inc. ReShape Lifesciences Inc.

ReShape Lifesciences Inc.

RSLS
Classificação em ações #36770
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences... Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.
Preço da ação
$3.92
Última sincronização: 2025-08-14
Valor de mercado
$2.34M
Variação (1 dia)
-69.38%
Variação (1 ano)
0.00%
País
US
Negociar ReShape Lifesciences Inc. (RSLS)

Categoria

Preço RSLS com a capitalização de mercado de B
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
RSLS
$3.92
Capitalização de mercado de ReShape Lifesciences Inc.(RSLS)
Valor de mercado: $2.34M
Em August 2026, ReShape Lifesciences Inc. tem uma capitalização de mercado de $2.34M. Isso faz com que ReShape Lifesciences Inc. seja a 36770th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de ReShape Lifesciences Inc. de 2019 a 2026
RSLS comparado com o topo de 5 mais populares stocks
Preço para RSLS Ativo B Capitalização de mercado de B Resultados
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$9,139,571 $2.34M
$5.452T +233,152,220.33%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$7,527,119 $2.34M
$4.490T +192,018,245.26%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,977,905 $2.34M
$4.162T +178,007,676.79%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,163,061 $2.34M
$3.676T +157,220,840.04%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$4,749,344 $2.34M
$2.833T +121,156,629.05%